Asia-Pacific Americas Africa Europe Middle East

PT ACTAVIS INDONESIA

Company Profile:

Company Introduction

PT Actavis Indonesia was a prominent pharmaceutical company operating in Indonesia. It was part of the global Actavis Group, which was a leading multinational pharmaceutical organization. Over time, Actavis became a part of Allergan plc, and subsequently, many of its assets and operations were acquired by Teva Pharmaceutical Industries Ltd., making it one of the largest generic drug manufacturers in the world.

In Indonesia, PT Actavis Indonesia focused on the development, manufacturing, and marketing of a wide range of pharmaceutical products. Their portfolio typically included generic prescription drugs, over-the-counter (OTC) medications, and other healthcare-related products, catering to the needs of the Indonesian healthcare market. The company was committed to providing high-quality, accessible, and affordable medicines to patients.

Business Type

PT Actavis Indonesia is a factory (manufacturer). The company was directly involved in the production, formulation, and packaging of pharmaceutical products.

Enterprise Products

PT Actavis Indonesia manufactures and/or markets a wide range of pharmaceutical products, including:

* **Generic Medicines:** Various therapeutic areas covered.

* **Branded Generics:** Medicines with recognized brand names but off-patent.

* **Over-the-Counter (OTC) Products:** Medications available without a prescription.

* **Prescription Medicines:** Medications requiring a doctor's prescription.

* **Vitamins and Supplements:** Products aimed at improving health and well-being.

Please note that specific product availability may vary over time. It's advisable to check the company's official website or local pharmaceutical resources for the most up-to-date information.

Business Registration Information:

Manager:

No Data

Phone:

+62 21 2995 9100

E-mail:

No Data

Official Website:
Address:

World Trade Center 2, 16th Floor Jl. Jend. Sudirman Kav. 29-31 Jakarta 12920, Indonesia

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.